tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Holding TSHA?
Track your performance easily

Taysha Gene Therapies (TSHA) Financial Statements

849 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently ―. The company's EPS TTM is $-0.87; its P/E ratio is -2.47; Taysha Gene Therapies is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.11M$ 3.41M$ 3.60M$ 4.75M$ 2.40M
Gross Profit$ 1.11M$ 3.41M$ 3.60M$ 4.75M$ 2.40M
EBIT$ -20.90M$ -22.64M$ 48.44M$ -115.60M$ -23.15M
EBITDA$ -20.26M$ -22.02M$ 49.08M$ -114.96M$ -22.48M
Net Income Common Stockholders$ -20.93M$ -24.06M$ 47.73M$ -117.07M$ -24.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 172.70M$ 124.00M$ 143.90M$ 164.30M$ 45.08M
Total Assets$ 200.39M$ 153.00M$ 172.73M$ 195.77M$ 81.54M
Total Debt$ 55.97M$ 59.01M$ 59.46M$ 57.65M$ 57.88M
Net Debt$ -116.73M$ -64.99M$ -84.44M$ -106.65M$ 12.80M
Total Liabilities$ 91.53M$ 99.15M$ 97.79M$ 244.88M$ 118.60M
Stockholders Equity$ 108.87M$ 53.85M$ 74.94M$ -49.11M$ -37.15M
Cash Flow-
Free Cash Flow$ -21.70M$ -19.94M$ -16.13M$ -17.95M$ -18.69M
Operating Cash Flow$ -21.50M$ -19.80M$ -16.12M$ -17.95M$ -18.74M
Investing Cash Flow$ -201.00K$ -140.00K$ -10.00K$ -3.49M$ 48.00K
Financing Cash Flow$ 70.47M$ -22.00K$ -4.25M$ 140.63M$ 377.00K
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Taysha Gene Therapies Debt to Assets

Taysha Gene Therapies Cash Flow

Taysha Gene Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis